Xylo Technologies Ltd. (XYLO)
NASDAQ: XYLO · IEX Real-Time Price · USD
1.755
-0.005 (-0.28%)
At close: Jul 19, 2024, 4:00 PM
1.790
+0.035 (1.99%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Xylo Technologies Market Cap
Xylo Technologies has a market cap or net worth of $3.41 million as of July 22, 2024. Its market cap has decreased by -54.58% in one year.
Market Cap
3.41M
Enterprise Value
-1.57M
1-Year Change
-54.58%
Ranking
Category
Stock Price
Market Cap Chart
Since August 5, 2015, Xylo Technologies's market cap has decreased from $29.00M to $3.41M, a decrease of -88.25%. That is a compound annual growth rate of -21.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 3.30M | -38.89% |
| Dec 29, 2023 | 5.40M | -29.87% |
| Dec 30, 2022 | 7.70M | -51.27% |
| Dec 31, 2021 | 15.80M | 28.46% |
| Dec 31, 2020 | 12.30M | 86.36% |
| Dec 31, 2019 | 6.60M | 164.00% |
| Dec 31, 2018 | 2.50M | 108.33% |
| Dec 29, 2017 | 1.20M | -66.67% |
| Dec 30, 2016 | 3.60M | -79.07% |
| Dec 31, 2015 | 17.20M | -40.69% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Portage Biotech | 3.58M |
| Ensysce Biosciences | 3.50M |
| Avenue Therapeutics | 3.42M |
| Protagenic Therapeutics | 3.40M |
| ZyVersa Therapeutics | 3.39M |
| Aditxt | 3.31M |
| Cingulate | 3.31M |
| CNS Pharmaceuticals | 3.13M |